Inflammatory processes are firmly established as central to the development and
complications of cardiovascular diseases. Elevated levels of inflammatory markers have …

Objective: To review the role of inflammatory suppression in patients with atherosclerotic
cardiovascular disease (ASCVD) with a focus on the interleukin-1β blocker canakinumab …

The recognition of atherogenesis as an active process rather than a passive cholesterol
storage disease has underlined key inflammatory mechanisms. Hence, innate and adaptive …

Cardiovascular disease is the leading cause of morbidity and mortality world-wide. Recently,
the role of inflammation in the progression of diseases has significantly attracted …

Atherosclerosis is an inflammatory disease within the arterial wall that is responsible for
several important adverse vascular events, including coronary artery disease, myocardial …

Inflammation plays a pivotal role in all stages of atherogenesis, from foam cell to plaque
formation to rupture and ultimately to thrombosis. Insight gained from recent basic and …

Inflammation is a pathogenic response to multiple factors, that causes over-activation of
different molecules and pro-inflammatory cellular lines. Different behavioral factors and risk …

Atherosclerosis is a multifactorial disease triggered and sustained by different risk factors
such as dyslipidemia, arterial hypertension, diabetes mellitus, smoke, etc. Since a couple of …

Systemic vascular inflammation plays multiple maladaptive roles which contribute to the
progression and destabilization of atherosclerotic cardiovascular disease (ASCVD). These …

Over the past two decades, the viewpoint of atherosclerosis has been replaced gradually by
a lipiddriven, chronic, low-grade inflammatory disease of the arterial wall. Current treatment …